Predictors of recovery of ovarian function during aromatase inhibitor therapy
N. Lynn Henry(University of Michigan), Daniel F. Hayes(University of Michigan–Ann Arbor), Ann H. Partridge(Dana-Farber Cancer Institute), Anne F. Schott(University of Michigan), Vered Stearns(Johns Hopkins University), Christina L. Gersch(University of Michigan), Rong Xia, Donald Giacherio, Daniel McConnell(University of Michigan), Mark D. Pearlman(University of Michigan), Mousumi Banerjee
Cited by 46
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k